Company Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd

Equities

600721

CNE000000KQ1

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 30/04/2024 am IST			5-day change	1st Jan Change
6.05 ^CNY	+2.54%		+19.80%	-21.83%

25/04	Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
25/04	Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Xinjiang Bai Hua Cun Pharma Tech Co Ltd is a China-based company principally engaged in pharmaceutical services. The Company's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The Company is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The Company is also engaged in leasing and property services. The Company mainly conducts business within the domestic market.

Number of employees: 731

CNY in Million	2022	Weight	2023	Weight	Delta
Medical Research and Development and Consistency Evaluation 51.9 %	184	52.5 %	192	51.9 %	+4.38%
Clinical Trials 38.6 %	136	38.8 %	143	38.6 %	+4.96%
Leasing and Property Services 7.5 %	22	6.4 %	28	7.5 %	+23.19%
Principal Business - Other 1.1 %	4	1.2 %	4	1.1 %	-3.44%
Advertising 0.8 %	3	1.0 %	3	0.8 %	-13.25%
Trademark Right 0.0 %	0	0.0 %	0	0.0 %	-.--%
Others 0.0 %	0	0.0 %	0	0.0 %	+14.09%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	350	100.0 %	369	100.0 %	+5.54%

Managers	Title	Age	Since
Hui Huang CEO	Chief Executive Officer	40	24/20/24
Zi Yun Cai DFI	Director of Finance/CFO	51	24/17/24
Yan Xia BRD	Director/Board Member	44	17/21/17
Zheng Tian Lü BRD	Director/Board Member	60	13/15/13
Li Juan Han IRC	Investor Relations Contact	33	12/23/12

Members of the board	Title	Age	Since
Jing Song Wang BRD	Director/Board Member	60	17/21/17
Da Ming Li BRD	Director/Board Member	57	28/18/28
Li Gu BRD	Director/Board Member	55	21/12
Hui Huang CEO	Chief Executive Officer	40	24/20/24
Xing Yu Lu BRD	Director/Board Member	36	17/21/17
Qing Yang BRD	Director/Board Member	61	06/19/06
Jian Bin Sun BRD	Director/Board Member	52	06/19/06
Bin Ma CHM	Chairman	52	06/19/06
Yan Xia BRD	Director/Board Member	44	17/21/17
Lei Meng BRD	Director/Board Member	41	17/21/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	381,822,020	210,836,664 ( 55.22 %)	0	55.22 %

Name	Equities	%	Valuation
Western Leadbank Fund Management Co., Ltd 0.1252 %	469,700	0.1252 %	405 530 ¥
GF Fund Management Co., Ltd. 0.000107 %	400	0.000107 %	345 ¥

Xinjiang Baihuacun Pharam Tech Co., Ltd.

1 South Lane Zhongshan Road

830002, Urumqi

http://www.xjbhc.net

address Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd(600721)

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD	-21.83%	319M
VERTEX PHARMACEUTICALS INCORPORATED	-1.65%	104B
REGENERON PHARMACEUTICALS, INC.	+6.75%	97.47B
ARGENX SE	+5.71%	22.25B
BIONTECH SE	-12.60%	21.68B
GENMAB A/S	-9.70%	18.2B
WUXI APPTEC CO., LTD.	-39.98%	17.02B
BEIGENE, LTD.	-10.17%	16.36B
NEUROCRINE BIOSCIENCES, INC.	+6.12%	14.39B
SAREPTA THERAPEUTICS, INC.	+35.47%	12.37B

Bio Therapeutic Drugs